COVID-19

CDC Knowingly Shipped Flawed COVID-19 Test Kits to Public Labs in Early Days of Crisis, Says Report

Early missteps characterized the federal government’s initial efforts to ensure a supply of reliable COVID-19 diagnostic tests in response to the public health emergency. And now a new National Public Radio (NPR) report contends that the U.S. Centers for Disease Control and Prevention (CDC) deliberately sent test kits to public labs despite knowing that they were apt to fail to 33 percent of the time.

The CDC’s Decision

The Nov. 6 report’s conclusion is based on a “root-cause analysis” internal review that the CDC conducted to understand why its early RT PCR coronavirus test didn’t work properly, costing scientists precious weeks in the early days of a pandemic.

The CDC test, the first to receive FDA emergency use authorization for COVID-19, was designed and built in record time. According to NPR, the tests were all boxed up and ready to go on February 6 when a scientist in an infectious disease lab on the CDC’s Atlanta campus discovered the high failure rate while putting the test kit through its final paces.

Normally, a failure rate of that magnitude would have precluded releasing the test. But the CDC apparently caved to the intense pressure and proceeded to distribute the test to about 100 public labs across the country, including the New York City Public Health Laboratory.

Problems with the CDC Lab

The CDC’s deliberate decision to release a flawed test kit wasn’t the only thing the root-cause analysis uncovered. The reviewers also determined that the CDC’s Respiratory Viruses Diagnostic Laboratory was beset with problems, including “process failures, a lack of appropriate recognized laboratory quality standards, and organizational problems related to the support and management of a laboratory supporting an outbreak response.”

The problems with the Respiratory Viruses Diagnostic Laboratory were reported last month by ProPublica. NPR’s story is the first time the CDC internal review’s findings have been made public. The CDC declined to discuss the review with NPR.

Takeaway

The decision of the CDC to rush an unproven if not faulty COVID-19 test kit to public labs in response to enormous public pressure is a cautionary tale that the agency and other scientific authorities will have to bear in mind when releasing a vaccine for the virus.

CLOSE TO VIEW ARTICLE x

You have 2 articles left to view this month.

Your 3 Free Articles Per Month Goes Very Quickly!
Get a 3 month Premium Membership to
one of our G2 Newsletters today!

Click on one of the Newsletters below to sign up now and get unlimited access to all articles, archives, and tools for that specific newsletter!

Close

EMAIL ADDRESS


PASSWORD
EMAIL ADDRESS

FIRST NAME

LAST NAME

TITLE

COMPANY

PHONE

Try Premium Membership

(-00000g2)